Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes, Hepatology, vol.17, issue.4, pp.962-973, 2005. ,
DOI : 10.1002/hep.20819
URL : https://hal.archives-ouvertes.fr/hal-00313678
Hepatitis C testing, care and treatment: evolution over ten years in France, Hepatology, vol.46, p.625, 2007. ,
Hepatitis C Virus Genotypes and Viral Concentrations in Participants of a General Population Survey in the United States, Gastroenterology, vol.131, issue.2, pp.478-484, 2006. ,
DOI : 10.1053/j.gastro.2006.06.007
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends, Seminars in Liver Disease, vol.20, issue.Number 01, pp.1-16, 2000. ,
DOI : 10.1055/s-2000-9506
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-982, 2002. ,
DOI : 10.1056/NEJMoa020047
Peginterferon-??2a and Ribavirin Combination Therapy in Chronic Hepatitis C, Annals of Internal Medicine, vol.140, issue.5, pp.346-355, 2004. ,
DOI : 10.7326/0003-4819-140-5-200403020-00010
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, The Lancet, vol.358, issue.9286, pp.958-965, 2001. ,
DOI : 10.1016/S0140-6736(01)06102-5
The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies, Gastroenterology, vol.132, issue.5, pp.1979-1998, 2007. ,
DOI : 10.1053/j.gastro.2007.03.116
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.1839-1850, 2009. ,
DOI : 10.1056/NEJMoa0807650
URL : https://hal.archives-ouvertes.fr/inserm-00385235
4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON??? (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C, Journal of Hepatology, vol.50, p.4, 2009. ,
DOI : 10.1016/S0168-8278(09)60006-4
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.360, issue.18, pp.1827-1838, 2009. ,
DOI : 10.1056/NEJMoa0806104
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment, Antivir Ther, vol.14, pp.23-32, 2009. ,
8 POTENT HCV PROTEASE INHIBITORS WITH THE POTENTIAL FOR ONCE-DAILY DOSING AND BROAD GENOTYPE COVERAGE, Journal of Hepatology, vol.50, issue.1, p.6, 2009. ,
DOI : 10.1016/S0168-8278(09)60010-6
Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors, Gastroenterology, vol.135, issue.5, pp.1710-1718, 2008. ,
DOI : 10.1053/j.gastro.2008.07.023
BMS-790052 is a first-in-class potent hepatitis C virus (HCV) NS5A inhibitor for patients with chronic HCV infection: results from a proof-of-concept study, Hepatology, vol.48, p.1025, 2008. ,
90 PRECLINICAL STUDIES OF ANA598 COMBINED WITH OTHER ANTI-HCV AGENTS DEMONSTRATE POTENTIAL OF COMBINATION TREATMENT, Journal of Hepatology, vol.50, issue.1, p.37, 2009. ,
DOI : 10.1016/S0168-8278(09)60092-1
Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs, Therapeutic Advances in Gastroenterology, vol.282, issue.1, pp.205-219, 2009. ,
DOI : 10.1177/1756283X09336045
GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796, Antimicrobial Agents and Chemotherapy, vol.53, issue.5, pp.2129-2132, 2009. ,
DOI : 10.1128/AAC.01598-08
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients, Hepatology, vol.44, issue.3, pp.631-639, 2007. ,
DOI : 10.1002/hep.21781
Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir, Gastroenterology, vol.132, issue.5, pp.1767-1777, 2007. ,
DOI : 10.1053/j.gastro.2007.02.037
Analysis of HCV NS5B genetic variants following monotherapy with HCV-796, a non-nucleoside polymerase inhibitor, in treatment-naive HCV-infected patients, Hepatology, vol.44, issue.1, pp.607-608, 2006. ,
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes, Best Practice & Research Clinical Gastroenterology, vol.22, issue.6, pp.1031-1048, 2008. ,
DOI : 10.1016/j.bpg.2008.11.004
URL : https://hal.archives-ouvertes.fr/inserm-00368349
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region, Journal of General Virology, vol.74, issue.11, pp.2391-2399, 1993. ,
DOI : 10.1099/0022-1317-74-11-2391
Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin, Gastroenterology, vol.131, issue.4, pp.1040-1048, 2006. ,
DOI : 10.1053/j.gastro.2006.07.022
HCV genotyping using statistical classification approach, Journal of Biomedical Science, vol.16, issue.1, p.62, 2009. ,
DOI : 10.1186/1423-0127-16-62
URL : http://doi.org/10.1186/1423-0127-16-62
Hepatitis C Virus Genotyping: Interrogation of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1b, Journal of Clinical Microbiology, vol.40, issue.9, pp.3127-3134, 2002. ,
DOI : 10.1128/JCM.40.9.3127-3134.2002
Genotyping of hepatitis C virus isolates by a new line probe assay using sequence information from both the 5???untranslated and the core regions, Journal of Virological Methods, vol.143, issue.2, pp.153-160, 2007. ,
DOI : 10.1016/j.jviromet.2007.03.006
Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay, Journal of Clinical Microbiology, vol.45, issue.4, pp.1140-1145, 2007. ,
DOI : 10.1128/JCM.01982-06
URL : https://hal.archives-ouvertes.fr/hal-01076948
Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region, Journal of Clinical Microbiology, vol.41, issue.4, pp.1558-1564, 2003. ,
DOI : 10.1128/JCM.41.4.1558-1564.2003
Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0, Journal of Clinical Microbiology, vol.46, issue.6, pp.1901-1906, 2008. ,
DOI : 10.1128/JCM.02390-07
Evaluation of a New Assay in Comparison with Reverse Hybridization and Sequencing Methods for Hepatitis C Virus Genotyping Targeting Both 5' Noncoding and Nonstructural 5b Genomic Regions, Journal of Clinical Microbiology, vol.46, issue.1, pp.192-197, 2008. ,
DOI : 10.1128/JCM.01623-07
Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns, Journal of General Virology, vol.82, issue.5, pp.1001-1012, 2001. ,
DOI : 10.1099/0022-1317-82-5-1001
PHYLIP: phylogeny inference package, version 3.5c (computer program) Distributed by the author, 1993. ,
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Research, vol.22, issue.22, pp.4673-4680, 1994. ,
DOI : 10.1093/nar/22.22.4673
Hepatitis C Virus Evolutionary Patterns Studied Through Analysis of Full-Genome Sequences, Journal of Molecular Evolution, vol.54, issue.1, pp.62-70, 2002. ,
DOI : 10.1007/s00239-001-0018-9
Dendroscope: An interactive viewer for large phylogenetic trees, BMC Bioinformatics, vol.8, issue.1, p.460, 2007. ,
DOI : 10.1186/1471-2105-8-460
WWW-query: An on-line retrieval system for biological sequence banks, Biochimie, vol.78, issue.5, pp.364-369, 1996. ,
DOI : 10.1016/0300-9084(96)84768-7
URL : https://hal.archives-ouvertes.fr/hal-00435034